Literature DB >> 23576643

Diagnostic delay in malignant pleural mesothelioma due to physicians fixation on history with non-exposure to asbestos.

Poul Henning Madsen1, Christian B Laursen, Jesper Rømhild Davidsen.   

Abstract

To establish the diagnosis of virtually any disease, the clinician must combine a variety of information. Often emphasised in this context is thorough medical history-taking including information on exposure to factors leading to or being associated with the disease in question. Continuous assessment of all available information is of utmost importance, as fixation on single details can be misguiding with inappropriate consequences in both the diagnostic and therapeutic approach. This case report presents how an atypical medical history led to a delay in the diagnosis of malignant pleural mesothelioma due to a low a priori likelihood of the disease because of non-exposure to asbestos. We highlight the fact that postrationalisation and attempts to renew a diagnostic approach must be carried out each time diagnostic dilemmas emerge, and when some or all diagnostic clues disagree.

Entities:  

Mesh:

Year:  2013        PMID: 23576643      PMCID: PMC3645896          DOI: 10.1136/bcr-2012-007491

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Undue delay in the diagnosis of lung cancer due to the clinician's preoccupation with pre-existing tuberculosis.

Authors:  Swaroop Revannasiddaiah; Irappa Madabhavi; Priyanka Thakur; Rajeev Kumar Seam
Journal:  BMJ Case Rep       Date:  2011-12-01

Review 2.  Malignant mesothelioma.

Authors:  S C-H Kao; G Reid; K Lee; J Vardy; S Clarke; N van Zandwijk
Journal:  Intern Med J       Date:  2010-11       Impact factor: 2.048

Review 3.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

4.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

5.  Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.

Authors:  K Antman; R Shemin; L Ryan; K Klegar; R Osteen; T Herman; G Lederman; J Corson
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

Review 6.  Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.

Authors:  D Curran; T Sahmoud; P Therasse; J van Meerbeeck; P E Postmus; G Giaccone
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

Review 7.  Mesothelioma epidemiology, carcinogenesis, and pathogenesis.

Authors:  Haining Yang; Joseph R Testa; Michele Carbone
Journal:  Curr Treat Options Oncol       Date:  2008-08-15
  7 in total
  1 in total

Review 1.  Malignant pleural mesothelioma: an update on diagnosis and treatment options.

Authors:  Sanjana Kondola; David Manners; Anna K Nowak
Journal:  Ther Adv Respir Dis       Date:  2016-02-12       Impact factor: 4.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.